Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Mallinckrodt
Teva
Daiichi Sankyo
UBS
McKesson
Federal Trade Commission
Chinese Patent Office
US Army

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078011

« Back to Dashboard

NDA 078011 describes VINORELBINE TARTRATE, which is a drug marketed by Actavis Totowa, Dr Reddys Labs Ltd, Ebewe Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Teva Pharms Usa, and West-ward Pharms Int, and is included in ten NDAs. It is available from four suppliers. Additional details are available on the VINORELBINE TARTRATE profile page.

The generic ingredient in VINORELBINE TARTRATE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.
Summary for 078011
Tradename:VINORELBINE TARTRATE
Applicant:Actavis Totowa
Ingredient:vinorelbine tartrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 078011
Ingredient-typeVinca Alkaloids
Suppliers and Packaging for NDA: 078011
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 078011 ANDA Actavis Pharma, Inc. 45963-607 45963-607-56 1 VIAL, SINGLE-USE in 1 CARTON (45963-607-56) > 5 mL in 1 VIAL, SINGLE-USE
VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 078011 ANDA Actavis Pharma, Inc. 45963-607 45963-607-55 1 VIAL, SINGLE-USE in 1 CARTON (45963-607-55) > 1 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Jul 22, 2009TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
UBS
Fuji
Cipla
Covington
Colorcon
Cerilliant
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot